Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Documenti analoghi

• Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease
  di: Paolo Gionchetti, et al.
  Pubblicazione: (2017)
• Adalimumab in active ulcerative colitis: A “real-life” observational study
  di: Alessandro Armuzzi, et al.
  Pubblicazione: (2013)
• Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort
  di: Ambrogio Orlando, et al.
  Pubblicazione: (2014)
• Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
  di: Rita Monterubbianesi, et al.
  Pubblicazione: (2014)
• Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
  di: Daperno, Marco, et al.
  Pubblicazione: (2019)